Novartis AG (NVS)
148.12
-1.00
(-0.67%)
USD |
NYSE |
Jun 10, 16:00
150.00
+1.88
(+1.27%)
Pre-Market: 06:04
Novartis EPS Diluted (TTM) : 7.017 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 7.017 |
| December 31, 2025 | 7.186 |
| September 30, 2025 | 7.333 |
| June 30, 2025 | 6.886 |
| March 31, 2025 | 6.378 |
| December 31, 2024 | 5.863 |
| September 30, 2024 | 8.574 |
| June 30, 2024 | 7.849 |
| March 31, 2024 | 7.367 |
| December 31, 2023 | 7.144 |
| September 30, 2023 | 3.724 |
| June 30, 2023 | 3.593 |
| March 31, 2023 | 3.255 |
| December 31, 2022 | 3.164 |
| September 30, 2022 | 9.716 |
| June 30, 2022 | 10.22 |
| March 31, 2022 | 10.74 |
| December 31, 2021 | 10.65 |
| September 30, 2021 | 4.333 |
| June 30, 2021 | 3.950 |
| March 31, 2021 | 3.478 |
| December 31, 2020 | 3.518 |
| September 30, 2020 | 3.091 |
| June 30, 2020 | 3.140 |
| March 31, 2020 | 5.244 |
| Date | Value |
|---|---|
| December 31, 2019 | 5.049 |
| September 30, 2019 | 5.069 |
| June 30, 2019 | 4.874 |
| March 31, 2019 | 5.271 |
| December 31, 2018 | 5.379 |
| September 30, 2018 | 5.708 |
| June 30, 2018 | 5.894 |
| March 31, 2018 | 3.413 |
| December 31, 2017 | 3.25 |
| September 30, 2017 | 2.81 |
| June 30, 2017 | 2.74 |
| March 31, 2017 | 2.66 |
| December 31, 2016 | 2.80 |
| September 30, 2016 | 2.84 |
| June 30, 2016 | 2.80 |
| March 31, 2016 | 2.80 |
| December 31, 2015 | 7.28 |
| September 30, 2015 | 7.45 |
| June 30, 2015 | 7.99 |
| March 31, 2015 | 8.290 |
| December 31, 2014 | 4.190 |
| September 30, 2014 | 4.400 |
| June 30, 2014 | 3.990 |
| March 31, 2014 | 3.951 |
| December 31, 2013 | 3.705 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AstraZeneca PLC | 3.330 |
| GSK Plc | 3.824 |
| Johnson & Johnson | 8.649 |
| Eli Lilly & Co. | 27.78 |
| Merck & Co., Inc. | 3.553 |